AAM
AVNR

Alpine Associates Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Alpine Associates Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,027,177
Closed -$51.3M – 127
2014
Q4 		$51.3M Buy
+3,027,177
New +$42.6M 1.57% 20

Alpine Associates Management's AVNR Position: Q1 2015 in Review

Alpine Associates Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 3,027,177 shares — an estimated $51.3M sold.

Alpine Associates Management first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $51.3M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Alpine Associates Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Alpine Associates Management sold 3,027,177 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $51.3M.
  • Alpine Associates Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • Alpine Associates Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $51.3M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Alpine Associates Management's 13F filing for Q1 2015, filed 13 May 2015.